Summary
The purpose of the present study was to examine the development of tolerance to three structurally dissimilar pyrogens, i.e., lipopolysaccharide (LPS), muramyl dipeptide (MDP) and polyinosinic: polycytidylic acid (poly I:C) in rabbits. The possibility of pyrogenic cross-tolerance among these agents has also been studied. It was observed that repeated injection of sublethal doses of LPS and MDP was connected with the changing of biphasic fever to monophasic. The consequence of this was a drop in the fever index. In contrast to LPS and MDP, the repeated administration of poly I:C did not result in such changes. Successive injections of this pyrogen always evoked biphasic fever. We also demonstrated that pyrogenic cross-tolerance between LPS and MDP did not occur. The cross-tolerance between LPS and MDP did not occur. The cross-tolerance among pyrogens was possible if they originated from the same class, for example endotoxin fromSalmonella abortus eq. and endotoxin fromEscherichia coli.
Similar content being viewed by others
Literatur
Dinarello, C. A., and Wolff, S. M., in: Handb. exp. Pharmac. 60: Pyretics and Antipyretics, pp. 73–112. Ed. A. S. Milton, Springer-Verlag, Berlin 1982.
Hellon, R., and Townsend, Y., Pharmac. Ther.19 (1983) 211.
Kozak, W., Milton, A. S., Abul, H., Davidson, J., and Rotondo, D., Cell. Signaling4 (1989) 345.
Bernheim, H. A., Yale J. biol. Med.59 (1986) 151.
Milton, A. S., in: Handbook of Experimental Pharmacology. 60: Pyretics and Antipyretics, pp. 257–303. Ed. A. S. Milton. Springer-Verlag, Berlin 1982.
Kotani, S., Azuma, I., Takada, H., Tsujimoto, M., and Yamamura, Y., in: Biological Response Modifiers in Human Oncology and Immunology, pp. 117–158. Eds T. Klein, S. Specter, H. Friedman and A. Szentivanyi. Plenum, New York 1983.
Dinarello, C. A., and Krueger, J. M., Fedn Proc.45 (1986) 2545.
Dinarello, C. A., Rev. infec. Dis.6 (1984) 51.
Won, S. J., and Lin, M. T., Am. J. Physiol.23 (1988) 499.
Dinarello, C. A., Bernheim, H. A., Duff, G. W., Le, H. V., Nagabhushan, T. L., Hamilton, N. C., and Coceani, F. J. clin. Invest.74 (1984) 906.
Bligh, J., in: Handbook of Experimental Pharmacology. 60: Pyretics and Antipyretics, pp. 25–71. Ed. A. S. Milton. Springer-Verlag, Berlin 1982.
Dinarello, C. A., Elin, R. J., and Chedid, L., J. infec. Dis.138 (1978) 760.
Silverman, D. H. S., Krueger, J. M., and Karnovsky, M. L., J. Immunol.136 (1986) 2195.
Wright, S. D., and Jong, M. T. C., J. exp. Med.164 (1986) 1876.
Torrence, P. F., and De Clercq, E., in: Handbook of Experimental Pharmacology. 71: Interferons and their Applications, pp. 233–258. Eds P. E. Came and W. A. Carter. Springer-Verlag, Berlin 1984.
Wielckens, K., Deles, T., Muth, A., Freese, V., and Kleeberg, H.-J.. J. Steroid Biochem.27 (1987) 413.
Zor, U., Ostfeld, J., Talmon, J., and Lahar, Y., in: Advances in Prostaglandin, Tromboxane, and Leukotriene Research, pp. 519–523. Eds B. Samuelsson, P.Y.-K. Wong and F.F. Sun, Raven Press, New York 1989.
Suzuki, T., Jap. J. Bact.15 (1960) 294.
Besedovsky, H., Sorkin, E., Keller, M., and Miller, J. Proc. Soc. exp. Biol. Med.150 (1975) 466.
Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, J. S., Palladino, M. A. Jr., and O'Connor, J. V., J. exp. Med.163 (1986) 1433.
Durum, S. K., and Oppenheim, J. J., in: Fundamental Immunology, 2nd edn, pp. 639–661. Ed. W. E. Paul. Raven Press, New York 1989.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Soszynski, D., Kozak, W. & Szewczenko, M. Course of fever response to repeated administration of sublethal doses of lipopolysaccharides, polyinosinic: Polycytidylic acid and muramyl dipeptide to rabbits. Experientia 47, 43–47 (1991). https://doi.org/10.1007/BF02041248
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02041248